ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

CAM Therapies Should Be Held to Conventional Standards and Congress Should Toughen Dietary Supplements Act, IOM Panel Says.

January 21, 2005

Schwetz Replaces Koski As HHS Human Research Protections Director

February 7, 2003

Senate Subcommittee Agrees On $1.188 Billion NCI Budgt for FY 1985, $110 Million Increase Over ‘84

June 29, 1984

NCI Warns Of Pill’s Potential Tumor Threat

April 2, 1976

Solomon Gard Loses Final Cancer Battle

February 12, 1982

Pitot Named New NCAB Chairman

May 4, 1979